{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T05:28:36Z","timestamp":1688966916147},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s10014-016-0252-x","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T06:10:41Z","timestamp":1457071841000},"page":"191-199","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?"],"prefix":"10.1007","volume":"33","author":[{"given":"Shinjiro","family":"Fukami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus J.","family":"Riemenschneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Jakob","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"252_CR1","first-page":"164","volume-title":"The 2007 WHO classification of tumours of the central nervous system","author":"A Perry","year":"2007","unstructured":"Perry A, Louis D, Scheithauer B et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) The 2007 WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon, pp 164\u2013172","edition":"4"},{"key":"252_CR2","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL et al (1999) \u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046\u20132056","journal-title":"Cancer"},{"key":"252_CR3","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","volume":"94","author":"RG Weber","year":"1997","unstructured":"Weber RG, Bostrom J, Wolter M et al (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719\u201314724","journal-title":"Proc Natl Acad Sci USA"},{"key":"252_CR4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","volume":"20","author":"D Barski","year":"2010","unstructured":"Barski D, Wolter M, Reifenberger G et al (2010) Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol 20:623\u2013631","journal-title":"Brain Pathol"},{"key":"252_CR5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080","journal-title":"Science"},{"key":"252_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","volume":"187","author":"C Prives","year":"1999","unstructured":"Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112\u2013126","journal-title":"J Pathol"},{"key":"252_CR7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.1218351","volume":"336","author":"JE Purvis","year":"2012","unstructured":"Purvis JE, Karhohs KW, Mock C et al (2012) p53 dynamics control cell fate. Science 336:1440\u20131444","journal-title":"Science"},{"key":"252_CR8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/02688697.2010.522743","volume":"25","author":"E Abdelzaher","year":"2011","unstructured":"Abdelzaher E, El-Gendi SM, Yehya A et al (2011) Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg 25:707\u2013713","journal-title":"Br J Neurosurg"},{"key":"252_CR9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10143-002-0204-2","volume":"25","author":"PH Aguiar","year":"2002","unstructured":"Aguiar PH, Agner C, Simm R et al (2002) p53 Protein expression in meningiomas\u2014a clinicopathologic study of 55 patients. Neurosurg Rev 25:252\u2013257","journal-title":"Neurosurg Rev"},{"key":"252_CR10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/modpathol.3800111","volume":"17","author":"VJ Amatya","year":"2004","unstructured":"Amatya VJ, Takeshima Y, Inai K (2004) Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Mod Pathol 17:705\u2013710","journal-title":"Mod Pathol"},{"key":"252_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","volume":"79","author":"SY Yang","year":"2008","unstructured":"Yang SY, Park CK, Park SH et al (2008) Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79:574\u2013580","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"252_CR12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostrom","year":"2001","unstructured":"Bostrom J, Meyer-Puttlitz B, Wolter M et al (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661\u2013669","journal-title":"Am J Pathol"},{"key":"252_CR13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng894","volume":"31","author":"DV Bulavin","year":"2002","unstructured":"Bulavin DV, Demidov ON, Saito S et al (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 31:210\u2013215","journal-title":"Nat Genet"},{"key":"252_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10555-008-9127-x","volume":"27","author":"X Lu","year":"2008","unstructured":"Lu X, Nguyen TA, Moon SH et al (2008) The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev 27:123\u2013135","journal-title":"Cancer Metastasis Rev"},{"key":"252_CR15","first-page":"1876","volume":"63","author":"F Saito-Ohara","year":"2003","unstructured":"Saito-Ohara F, Imoto I, Inoue J et al (2003) PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res 63:1876\u20131883","journal-title":"Cancer Res"},{"key":"252_CR16","first-page":"1995","volume":"9","author":"A Hirasawa","year":"2003","unstructured":"Hirasawa A, Saito-Ohara F, Inoue J et al (2003) Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin Cancer Res 9:1995\u20132004","journal-title":"Clin Cancer Res"},{"key":"252_CR17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0002-9440(10)63463-3","volume":"163","author":"J Boom van den","year":"2003","unstructured":"van den Boom J, Wolter M, Kuick R et al (2003) Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163:1033\u20131043","journal-title":"Am J Pathol"},{"key":"252_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1750-3639.2002.tb00429.x","volume":"12","author":"R Buschges","year":"2002","unstructured":"Buschges R, Ichimura K, Weber RG et al (2002) Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas. Brain Pathol 12:145\u2013153","journal-title":"Brain Pathol"},{"key":"252_CR19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(86)91782-4","volume":"1","author":"J Yokota","year":"1986","unstructured":"Yokota J, Yamamoto T, Toyoshima K et al (1986) Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1:765\u2013767","journal-title":"Lancet"},{"key":"252_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1023081624133","volume":"78","author":"CS Sinclair","year":"2003","unstructured":"Sinclair CS, Rowley M, Naderi A et al (2003) The 17q23 amplicon and breast cancer. Breast Cancer Res Treat 78:313\u2013322","journal-title":"Breast Cancer Res Treat"},{"key":"252_CR21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/path.1925","volume":"208","author":"A Ehrbrecht","year":"2006","unstructured":"Ehrbrecht A, Muller U, Wolter M et al (2006) Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. J Pathol 208:554\u2013563","journal-title":"J Pathol"},{"key":"252_CR22","first-page":"1408","volume":"59","author":"FJ Couch","year":"1999","unstructured":"Couch FJ, Wang XY, Wu GJ et al (1999) Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer. Cancer Res 59:1408\u20131411","journal-title":"Cancer Res"},{"key":"252_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/81583","volume":"26","author":"JJ Jacobs","year":"2000","unstructured":"Jacobs JJ, Keblusek P, Robanus-Maandag E et al (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 26:291\u2013299","journal-title":"Nat Genet"},{"key":"252_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/FVNU-7UBY-DXE3-77MT","volume":"115","author":"DX Cai","year":"2001","unstructured":"Cai DX, James CD, Scheithauer BW et al (2001) PS6K amplification characterizes a small subset of anaplastic meningiomas. Am J Clin Pathol 115:213\u2013218","journal-title":"Am J Clin Pathol"},{"key":"252_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.20201","volume":"56","author":"EI Surace","year":"2004","unstructured":"Surace EI, Lusis E, Haipek CA et al (2004) Functional significance of S6K overexpression in meningioma progression. Ann Neurol 56:295\u2013298","journal-title":"Ann Neurol"},{"key":"252_CR26","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1073\/pnas.94.12.6048","volume":"94","author":"M Fiscella","year":"1997","unstructured":"Fiscella M, Zhang H, Fan S et al (1997) Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 94:6048\u20136053","journal-title":"Proc Natl Acad Sci USA"},{"key":"252_CR27","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1093\/emboj\/19.23.6517","volume":"19","author":"M Takekawa","year":"2000","unstructured":"Takekawa M, Adachi M, Nakahata A et al (2000) p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 19:6517\u20136526","journal-title":"EMBO J"},{"key":"252_CR28","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1093\/emboj\/17.16.4744","volume":"17","author":"M Takekawa","year":"1998","unstructured":"Takekawa M, Maeda T, Saito H (1998) Protein phosphatase 2C\u03b1 inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J 17:4744\u20134752","journal-title":"EMBO J"},{"key":"252_CR29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0014-5793(98)01229-0","volume":"437","author":"M Hanada","year":"1998","unstructured":"Hanada M, Kobayashi T, Ohnishi M et al (1998) Selective suppression of stress-activated protein kinase pathway by protein phosphatase 2C in mammalian cells. FEBS Lett 437:172\u2013176","journal-title":"FEBS Lett"},{"key":"252_CR30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng1317","volume":"36","author":"DV Bulavin","year":"2004","unstructured":"Bulavin DV, Phillips C, Nannenga B et al (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36:343\u2013350","journal-title":"Nat Genet"},{"key":"252_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng888","volume":"31","author":"J Li","year":"2002","unstructured":"Li J, Yang Y, Peng Y et al (2002) Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet 31:133\u2013134","journal-title":"Nat Genet"},{"key":"252_CR32","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1158\/1078-0432.CCR-08-2403","volume":"15","author":"DS Tan","year":"2009","unstructured":"Tan DS, Lambros MB, Rayter S et al (2009) PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin Cancer Res 15:2269\u20132280","journal-title":"Clin Cancer Res"},{"key":"252_CR33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jso.22004","volume":"104","author":"P Wang","year":"2011","unstructured":"Wang P, Rao J, Yang H et al (2011) Wip1 over-expression correlated with TP53\/p14(ARF) pathway disruption in human astrocytomas. J Surg Oncol 104:679\u2013684","journal-title":"J Surg Oncol"},{"key":"252_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-005-9017-7","volume":"95","author":"J Rauta","year":"2006","unstructured":"Rauta J, Alarmo EL, Kauraniemi P et al (2006) The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res Treat 95:257\u2013263","journal-title":"Breast Cancer Res Treat"},{"key":"252_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-4608(97)00394-4","volume":"103","author":"J Khan","year":"1998","unstructured":"Khan J, Parsa NZ, Harada T et al (1998) Detection of gains and losses in 18 meningiomas by comparative genomic hybridization. Cancer Genet Cytogenet 103:95\u2013100","journal-title":"Cancer Genet Cytogenet"},{"key":"252_CR36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bmcl.2011.10.084","volume":"22","author":"H Yagi","year":"2012","unstructured":"Yagi H, Chuman Y, Kozakai Y et al (2012) A small molecule inhibitor of p53-inducible protein phosphatase PPM1D. Bioorg Med Chem Lett 22:729\u2013732","journal-title":"Bioorg Med Chem Lett"},{"key":"252_CR37","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-10-0697","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Wan G, Mlotshwa S et al (2010) Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res 70:7176\u20137186","journal-title":"Cancer Res"},{"key":"252_CR38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3171\/2014.7.JNS132661","volume":"121","author":"MS Kim","year":"2014","unstructured":"Kim MS, Kim KH, Lee EH et al (2014) Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. J Neurosurg 121:1189\u20131200","journal-title":"J Neurosurg"},{"key":"252_CR39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2990.1995.tb01040.x","volume":"21","author":"DW Ellison","year":"1995","unstructured":"Ellison DW, Lunec J, Gallagher PJ et al (1995) Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21:136\u2013142","journal-title":"Neuropathol Appl Neurobiol"},{"key":"252_CR40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/mc.2940080203","volume":"8","author":"H Ohgaki","year":"1993","unstructured":"Ohgaki H, Eibl RH, Schwab M et al (1993) Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 8:74\u201380","journal-title":"Mol Carcinog"},{"key":"252_CR41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ijc.2910640402","volume":"64","author":"JL Wang","year":"1995","unstructured":"Wang JL, Zhang ZJ, Hartman M et al (1995) Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction\/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer 64:223\u2013228","journal-title":"Int J Cancer"},{"key":"252_CR42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ng.2995","volume":"46","author":"L Zhang","year":"2014","unstructured":"Zhang L, Chen LH, Wan H et al (2014) Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nat Genet 46:726\u2013730","journal-title":"Nat Genet"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-016-0252-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-016-0252-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:34:17Z","timestamp":1559118857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-016-0252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1007\/s10014-016-0252-x","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}